Showing results (11-20 of 27) with videos related to
Sort By:
Pageof 3
Materials (Basel, Switzerland)|August 10, 2017
Drying of Pigment-Cellulose Nanofibril SubstratesOleg Timofeev, Katariina Torvinen, Jenni Sievänen, et al.Materials (Basel, Switzerland)|January 8, 2023
Influence of SHS Precursor Composition on the Properties of Yttria Powders and Optical CeramicsDmitry Permin, Olga Postnikova, Stanislav Balabanov, et al.Cell Stem Cell|March 29, 2008
Wip1 phosphatase regulates p53-dependent apoptosis of stem cells and tumorigenesis in the mouse intestineOleg N Demidov, Oleg Timofeev, Hnin N Y Lwin, et al.Proceedings of the National Academy of Sciences of the United States of America|October 16, 2019
Loss of p53 function at late stages of tumorigenesis confers ARF-dependent vulnerability to p53 reactivation therapyBoris Klimovich, Samet Mutlu, Jean Schneikert, et al.Cell Reports|May 14, 2013
p53 DNA binding cooperativity is essential for apoptosis and tumor suppression in vivoOleg Timofeev, Katharina Schlereth, Michael Wanzel, et al.Nature Genetics|March 3, 2004
Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16(Ink4a)-p19(Arf) pathwayDmitry V Bulavin, Crissy Phillips, Bonnie Nannenga, et al.Oncogene|December 15, 2021
p53 partial loss-of-function mutations sensitize to chemotherapyBoris Klimovich, Nastasja Merle, Michelle Neumann, et al.Seminars in Cancer Biology|May 11, 2026
Tumor microenvironment evaluation in lung cancer: Spatio-temporal dynamics and clinical implicationsSelma Dizdarević, Oleg Timofeev, Daniel Kazdal, et al.Journal of Experimental & Clinical Cancer Research : CR|March 2, 2022
Partial p53 reactivation is sufficient to induce cancer regressionBoris Klimovich, Laura Meyer, Nastasja Merle, et al.Cell Death & Disease|February 26, 2026
Targeting the p53 cancer mutants Y220C, Y220N, and Y220S with the small-molecule stabilizer rezatapoptDanai Mavridi, Julianne S Funk, Dimitrios-Ilias Balourdas, et al.Pageof 3